Dr. rer. nat. Clara Dees

Department of Medicine 3 – Rheumatology and Immunology

Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD (2025) Hong X, Xiao Y, Xu L, Shen L, Neelagar R, Devakumar V, Trinh-Minh T, et al. Journal article Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis (2024) Trinh-Minh T, Chen CW, Tran-Manh C, Li YN, Zhu H, Zhou X, Chakraborty D, et al. Journal article Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies (2024) Bergmann C, Chenguiti Fakhouri S, Trinh-Minh T, Filla T, Rius Rigau AR, Ekici AB, Merlevede B, et al. Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Assessment of myocardial fibrosis in patients with systemic sclerosis using [Ga-68]Ga-FAPI-04-PET-CT (2022) Treutlein C, Distler J, Tascilar K, Chenguiti Fakhouri S, Györfi AH, Atzinger A, Matei AE, et al. Journal article ASSESSMENT OF SYSTEMIC SCLEROSIS RELATED MYOCARDIAL FIBROSIS BY 68GA-FAPI-04 PET/CT (2022) Treutlein C, Schmidkonz C, Tascilar K, Chenguiti Fakhouri S, Dees C, Györfi AH, Matei AE, et al. Conference contribution, Abstract of a poster Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation (2021) Györfi AH, Matei AE, Fuchs M, Liang C, Rigau A, Hong X, Zhu H, et al. Journal article ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING (2021) Györfi AH, Matei AE, Fuchs M, Rigau A, Hong X, Honglin Z, Luber M, et al. Conference contribution 68GA-FAPI-04 PET/CT STUDY EXTENSION FOR THE ASSESSMENT OF FIBROBLAST ACTIVATION AND RISK EVALUATION IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Conference contribution NCOA3 AMPLIFIES PROFIBROTIC TRANSCRIPTIONAL PROGRAMS IN SYSTEMIC SCLEROSIS (2021) Dees C, Pötter S, Fuchs M, Bergmann C, Matei AE, Györfi AH, Soare A, et al. Conference contribution